Document is current

Any future updates will be listed below

Adjuvant benmelstobart plus anlotinib in patients with high-risk recurrence after resection of hepatocellular carcinoma: a phase II study (ALTER-H006)

Crossref DOI link: https://doi.org/10.1038/s41467-025-66342-2

Published Online: 2025-12-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark